Summary:
Clinical Research of Homestead is conducting a Phase III Study to Evaluate the Efficacy and Safety of 3 Doses of Benralizumab (MEDI-563) in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary
Disease (COPD) with a History of COPD Exacerbations
Qualified Participants Must:
• Have experienced an exacerbation and hospitalized in the last year
Qualified Participants May Receive:
Study medication and compensation for participation in the study.